33rd week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200254007 | METHOD OF PRODUCTION OF A BRANCHED ORGANOSILICONE POLYMEROUS POLYNUCLEAR ADSORBENT OF HIGH MOLECULAR TOXINS AND THIS ADSORBENT | 2020-08-13 |
20200254008 | KELOID PREVENTION OR TREATMENT METHOD USING LIQUID PHASE PLASMA | 2020-08-13 |
20200254009 | Potassium enriched topical formulations for pain relief and sleep aid | 2020-08-13 |
20200254010 | HYPOTHERMAL INHALATION GAS COMPOSITION | 2020-08-13 |
20200254011 | NANOCOMPOSITE FORMULATION FOR USE IN HEMOSTASIS | 2020-08-13 |
20200254012 | FUNCTIONAL SEGREGATED TELODENDRIMERS AND NANOCARRIERS AND METHODS OF MAKING AND USING SAME | 2020-08-13 |
20200254013 | COMPOSITIONS COMPRISING ALPHA-POLYGLUTAMIC ACID-ZINC FOR TREATING CANCER | 2020-08-13 |
20200254014 | ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THEIR PRODUCTION | 2020-08-13 |
20200254015 | COMBINED ORGAN AND HEMATOPOIETIC CELLS FOR TRANSPLANTATION TOLERANCE OF HLA MISMATCHED GRAFTS | 2020-08-13 |
20200254016 | COMPOSITIONS AND METHODS FOR PARENTERAL ADMINISTRATION OF THERAPEUTIC AGENTS | 2020-08-13 |
20200254017 | NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS | 2020-08-13 |
20200254018 | METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION | 2020-08-13 |
20200254019 | PHARMACEUTICAL PREPARATION | 2020-08-13 |
20200254020 | Methods and Compositions for Modulating the WNT-Signaling Pathway as Treatments for Inflammatory Diseases | 2020-08-13 |
20200254021 | Chimeric Antigen Receptor | 2020-08-13 |
20200254022 | NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS | 2020-08-13 |
20200254023 | CD123-Specific Chimeric Antigen Receptor Redirected T Cells and Methods of Their Use | 2020-08-13 |
20200254024 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS COMPRISING NASAL INFERIOR TURBINATE-DERIVED MESENCHYMAL STEM CELLS AS AN ACTIVE INGREDIENT | 2020-08-13 |
20200254025 | METHODS OF TREATING AN ISCHEMIC DISEASE | 2020-08-13 |
20200254026 | AGENT FOR PROMOTING MIGRATION OF PLURIPOTENT STEM CELLS | 2020-08-13 |
20200254027 | LYOPHILIZED COMPOSITIONS COMPRISING FECAL MICROBE-BASED THERAPEUTIC AGENTS AND METHODS FOR MAKING AND USING SAME | 2020-08-13 |
20200254028 | BACTERIAL EXTRACELLULAR VESICLES | 2020-08-13 |
20200254029 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | 2020-08-13 |
20200254030 | Combined Multistage Microbial Preparations and Method of Their Application | 2020-08-13 |
20200254031 | SYNBIOTIC COMPOSITION FOR PREVENTING METABOLIC DISORDERS | 2020-08-13 |
20200254032 | REDUCING CHOLESTEROL PROBIOTIC STRAIN AND USE THEREOF | 2020-08-13 |
20200254033 | COMPOSITION FOR PREVENTING AND IMPROVING GASTROINTESTINAL DISORDER CONTAINING LACTOBACILLUS PLANTARUM | 2020-08-13 |
20200254034 | LACTOBACILLUS PLANTARUM TCI378 AND ITS USES IN LOSING FAT AND IMPROVING GASTROINTESTINAL FUNCTIONS | 2020-08-13 |
20200254035 | PHAGE AND TRANSDUCTION PARTICLES | 2020-08-13 |
20200254036 | A VIRUS FOR TREATMENT OF TUMOR | 2020-08-13 |
20200254037 | TREATMENT OF TRIPLE NEGATIVE BREAST CANCER OR COLORECTAL CANCER WITH LIVER METASTASES WITH AN ANTI PD-L1 ANTIBODY AND AN ONCOLYTIC VIRUS | 2020-08-13 |
20200254038 | PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIS, USES THEREOF AND METHODS FOR IMPROVING SLEEP QUALITY | 2020-08-13 |
20200254039 | PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIS, USES THEREOF AND METHODS FOR IMPROVING SLEEP QUALITY | 2020-08-13 |
20200254040 | Pharmaceutical Compositions Containing Cannabis, Uses Thereof and Methods for Improving Energy Levels and/or Alleviating Fatigue | 2020-08-13 |
20200254041 | RAPID ONSET AND EXTENDED ACTION PLANT-BASED AND SYNTHETIC CANNABINOID FORMULATIONS | 2020-08-13 |
20200254042 | MEDICAL COMPOSITIONS AND KITS INCLUDING THOSE COMPOSITIONS III | 2020-08-13 |
20200254043 | COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF RESPIRATORY TRACT DISORDERS | 2020-08-13 |
20200254044 | COMPOSITION COMPRISING PLANT-DERIVED EXTRACELLULAR VESICLES | 2020-08-13 |
20200254045 | HERBAL PHARMACEUTICAL COMPOSITIONS AND METHOD OF PREPARATION THEREOF | 2020-08-13 |
20200254046 | PHARMACEUTICAL COMPOSITIONS | 2020-08-13 |
20200254047 | ORGANOLEPTIC DIETARY PRODUCT FROM FENUGREEK SEED, AND METHOD FOR PRODUCTION THEREOF | 2020-08-13 |
20200254048 | COMPOSITION FOR THE TREATMENT OF METABOLIC AND MECHANICAL NEUROPATHIES | 2020-08-13 |
20200254049 | Combination Therapy for Cancer | 2020-08-13 |
20200254050 | STABLE COMPOSITIONS OF NEUROACTIVE PEPTIDES | 2020-08-13 |
20200254051 | COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES | 2020-08-13 |
20200254052 | Sincalide Formulations | 2020-08-13 |
20200254053 | SYNTHETIC PEPTIDE COMPOUNDS AND METHODS OF USE | 2020-08-13 |
20200254054 | DAPTOMYCIN FORMULATIONS | 2020-08-13 |
20200254055 | COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES | 2020-08-13 |
20200254056 | MEDICATION FOR TREATING CELIAC DISEASE AND METHOD FOR PRODUCING SAME | 2020-08-13 |
20200254057 | NOVEL ANTIMICROBIAL PEPTIDE FROM SKATE SKIN AND USES THEREOF | 2020-08-13 |
20200254058 | THERAPEUTIC TREM-1 PEPTIDES | 2020-08-13 |
20200254059 | THERAPEUTIC AGENT OF UREMIA CONTAINING ALARIN AS THE MAIN INGREDIENT | 2020-08-13 |
20200254060 | COMPOSITIONS AND METHODS FOR DELIVERING CFTR POLYPEPTIDES | 2020-08-13 |
20200254061 | INJECTABLE BONE MORPHOGENETIC PROTEIN | 2020-08-13 |
20200254062 | COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS | 2020-08-13 |
20200254063 | METHODS AND COMPOSITIONS FOR MODULATION OF DYSREGULATED PLCG2 PHOSPHORYLATION | 2020-08-13 |
20200254064 | Thermostable Composition Having Antiviral and Antibacterial Activity and the Use Thereof | 2020-08-13 |
20200254065 | LONG-ACTING GLP-2 ANALOGS | 2020-08-13 |
20200254066 | PHARMACEUTICALS AND DOSING MEANS FOR HUMAN AGING REVERSAL | 2020-08-13 |
20200254067 | Pharmaceutical Compositions And Methods | 2020-08-13 |
20200254068 | METHODS FOR TREATING TRAUMATIC BRAIN INJURY | 2020-08-13 |
20200254069 | COMPOSITIONS FOR TREATING MACULAR EDEMA | 2020-08-13 |
20200254070 | Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors | 2020-08-13 |
20200254071 | COMPOSITIONS AND METHODS FOR THROMBOEMBOLISM DISSOLUTION | 2020-08-13 |
20200254072 | Stabilised Solid Compositions of Factor VII Polypeptides | 2020-08-13 |
20200254073 | ENHANCED DELIVERY OF ANTIOXIDANTS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS INVOLVING OXIDATIVE STRESS | 2020-08-13 |
20200254074 | ARGININE DEIMINASE ENCAPSULATED INSIDE ERYTHROCYTES AND THEIR USE IN TREATING CANCER AND ARGINASE-1 DEFICIENCY | 2020-08-13 |
20200254075 | METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED CONDITIONS | 2020-08-13 |
20200254076 | MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | 2020-08-13 |
20200254077 | Materials and Methods for Eliciting Targeted Antibody Responses In Vivo | 2020-08-13 |
20200254078 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) | 2020-08-13 |
20200254079 | COMPOSITIONS AND METHODS FOR THE INDUCTION OF CD8+ T-CELLS | 2020-08-13 |
20200254080 | RECOMBINANT BCG OVEREXPRESSSING phoP-phoR | 2020-08-13 |
20200254081 | COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE | 2020-08-13 |
20200254082 | NON-TOXIGENIC CLOSTRIDIUM DIFFICILE SPORES FOR USE IN ORAL VACCINATION | 2020-08-13 |
20200254083 | METHOD OF TREATMENT | 2020-08-13 |
20200254084 | NOVEL TILAPIA VIRUS AND USES THEREOF | 2020-08-13 |
20200254085 | IMMUNOGENIC COMPOSITIONS AGAINST INFLUENZA | 2020-08-13 |
20200254086 | EFFICACIOUS MRNA VACCINES | 2020-08-13 |
20200254087 | A RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS | 2020-08-13 |
20200254088 | MULTIVALENT FELINE VACCINE | 2020-08-13 |
20200254089 | VACCINE COMPOSITION AND ADJUVANT | 2020-08-13 |
20200254090 | USES OF MYOSTATIN ANTAGONISTS, COMBINATIONS CONTAINING THEM AND USES THEREOF | 2020-08-13 |
20200254091 | Combination of a PARP Inhibitor and a PD-1 Axis Binding Antagonist | 2020-08-13 |
20200254092 | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) | 2020-08-13 |
20200254093 | COMBINATION TREATMENT FOR CANCER | 2020-08-13 |
20200254094 | HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY | 2020-08-13 |
20200254095 | NANOSCALE METAL-ORGANIC LAYERS AND METAL-ORGANIC NANOPLATES FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RADIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF | 2020-08-13 |
20200254096 | METHOD AND SYSTEM FOR ADDING SENSORY CONDITIONING CUES IN A PHARMACOTHERAPEUTIC REGIMEN | 2020-08-13 |
20200254097 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2020-08-13 |
20200254098 | HOT MELT EXTRUSION COMPOSITION USING DIRECT COMPRESSIBLE EXCIPIENT AS PLASTICIZER | 2020-08-13 |
20200254099 | RADIOPAQUE POLYMERS | 2020-08-13 |
20200254100 | ANIONIC-CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS, AND METHODS OF MAKING AND USING THE SAME | 2020-08-13 |
20200254101 | TWO-DRUG TYPE LOCAL INJECTION SOLUTION FOR SUBMUCOSAL INJECTION | 2020-08-13 |
20200254102 | PROCESSING METHOD FOR BIOPOLYMERS USING SOLVENT COMBINATIONS | 2020-08-13 |
20200254103 | Method for treating neurological conditions and improving human cognition | 2020-08-13 |
20200254104 | METHODS OF MAKING AND USING PHYTOCANNABINOIDS COMPLEXED WITH A PROTEIN, PEPTIDE, AMINO ACID, POLYSACCHARIDE, DISACCHRIDE, OR MONOSACCHARIDE | 2020-08-13 |
20200254105 | DRUG COMPOSITION FOR PARENTERAL ADMINISTRATION | 2020-08-13 |
20200254106 | NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME | 2020-08-13 |